Julia Kubiak1, Elena Kamycheva2,3, Rolf Jorde2,3. 1. Tromsø Endocrine Research Group, Department of Clinical Medicine, UiT-The Arctic University of Norway, Tromsø, Norway. julia.magdalena.kubiak@unn.no. 2. Tromsø Endocrine Research Group, Department of Clinical Medicine, UiT-The Arctic University of Norway, Tromsø, Norway. 3. Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway.
Abstract
BACKGROUND/ OBJECTIVES: Our objective was to evaluate the degree of tracking for serum levels of 25-hydroxyvitamin D [25(OH)D] over time, by using data from three previously conducted surveys of the Tromsø study collected in the years 1994/1995 (Tromsø 4), 2007/2008 (Tromsø 6), and 2015/2016 (Tromsø 7). SUBJECTS/ METHODS: Subjects with valid 25(OH)D measurements in all three surveys were included. 25(OH)D z-scores were used to adjust for seasonal variation. Z-scores and sextiles were used to illustrate tracking of 25(OH)D. RESULTS: 1702 subjects (572 males, 1130 females) fulfilled the inclusion criteria. Median (5th, 95th percentiles) age for these subjects was 55 (33, 65) years in Tromsø 4, and mean (SD) 25(OH)D levels were 57 (18) nmol/L, 59 (19) nmol/L, and 72 (21) nmol/L for Tromsø 4, Tromsø 6, and Tromsø 7, respectively. There was significant tracking of serum 25(OH)D over the 21 years period between the surveys of the Tromsø study. The correlation coefficient r between 25(OH)D z-scores from Tromsø 4 and Tromsø 6 was 0.40, and declined to 0.29 for the correlation between Tromsø 4 and Tromsø 7. Twenty-six percent of the subjects in the lowest 25(OH)D z-score sextile in Tromsø 4 were in the three highest sextiles of 25(OH)D in Tromsø 7. Similarly, 35% of those in the highest sextile in Tromsø 4 were in the lowest three sextiles in Tromsø 7. CONCLUSIONS: The degree of tracking for serum 25(OH)D declines over time, and the use of a single serum 25(OH)D measurement as an indicator of the vitamin-D status is questionable if used in long-lasting observational studies.
BACKGROUND/ OBJECTIVES: Our objective was to evaluate the degree of tracking for serum levels of 25-hydroxyvitamin D [25(OH)D] over time, by using data from three previously conducted surveys of the Tromsø study collected in the years 1994/1995 (Tromsø 4), 2007/2008 (Tromsø 6), and 2015/2016 (Tromsø 7). SUBJECTS/ METHODS: Subjects with valid 25(OH)D measurements in all three surveys were included. 25(OH)D z-scores were used to adjust for seasonal variation. Z-scores and sextiles were used to illustrate tracking of 25(OH)D. RESULTS: 1702 subjects (572 males, 1130 females) fulfilled the inclusion criteria. Median (5th, 95th percentiles) age for these subjects was 55 (33, 65) years in Tromsø 4, and mean (SD) 25(OH)D levels were 57 (18) nmol/L, 59 (19) nmol/L, and 72 (21) nmol/L for Tromsø 4, Tromsø 6, and Tromsø 7, respectively. There was significant tracking of serum 25(OH)D over the 21 years period between the surveys of the Tromsø study. The correlation coefficient r between 25(OH)D z-scores from Tromsø 4 and Tromsø 6 was 0.40, and declined to 0.29 for the correlation between Tromsø 4 and Tromsø 7. Twenty-six percent of the subjects in the lowest 25(OH)D z-score sextile in Tromsø 4 were in the three highest sextiles of 25(OH)D in Tromsø 7. Similarly, 35% of those in the highest sextile in Tromsø 4 were in the lowest three sextiles in Tromsø 7. CONCLUSIONS: The degree of tracking for serum 25(OH)D declines over time, and the use of a single serum 25(OH)D measurement as an indicator of the vitamin-D status is questionable if used in long-lasting observational studies.
Authors: Rebecca J Moon; Sarah R Crozier; Elaine M Dennison; Justin H Davies; Sian M Robinson; Hazel M Inskip; Keith M Godfrey; Cyrus Cooper; Nicholas C Harvey Journal: Am J Clin Nutr Date: 2015-09-23 Impact factor: 7.045
Authors: Pawel Pludowski; Michael F Holick; Stefan Pilz; Carol L Wagner; Bruce W Hollis; William B Grant; Yehuda Shoenfeld; Elisabeth Lerchbaum; David J Llewellyn; Katharina Kienreich; Maya Soni Journal: Autoimmun Rev Date: 2013-03-28 Impact factor: 9.754
Authors: Michael C Sachs; Abigail Shoben; Gregory P Levin; Cassy Robinson-Cohen; Andrew N Hoofnagle; Nancy Swords-Jenny; Joachim H Ix; Matthew Budoff; Pamela L Lutsey; David S Siscovick; Bryan Kestenbaum; Ian H de Boer Journal: Am J Clin Nutr Date: 2013-04-24 Impact factor: 7.045
Authors: David A Jolliffe; Robert T Walton; Christopher J Griffiths; Adrian R Martineau Journal: J Steroid Biochem Mol Biol Date: 2015-12-11 Impact factor: 4.292
Authors: Helga H Hektoen; Trude E Robsahm; Jo S Stenehjem; Karol Axcrona; Ronnie Babigumira; Alison M Mondul; Randi E Gislefoss; Bettina K Andreassen Journal: Cancer Med Date: 2021-06-03 Impact factor: 4.452
Authors: Maike Wolters; Timm Intemann; Paola Russo; Luis A Moreno; Dénes Molnár; Toomas Veidebaum; Michael Tornaritis; Stefaan De Henauw; Gabriele Eiben; Wolfgang Ahrens; Anna Floegel Journal: Eur J Clin Nutr Date: 2021-07-23 Impact factor: 4.016